Article
The neuropeptide genes TAC1, TAC3, TAC4, VIP and PACAP(ADCYAP1), and susceptibility to multiple sclerosis.
Journal of neuroimmunology - 1 Feb 2007
Cunningham Stephen, O'Doherty Catherine, Patterson Chris, McDonnell Gavin, Hawkins Stanley, Marrosu Marria G, Vandenbroeck Koen
Abstract excerpt
The related immunomodulatory neuropeptides vasoactive intestinal peptide (VIP) and pituitary adenylyl cyclase activating peptide (PACAP; gene symbol ADCYAP1) have recently been proposed as novel therapeutics for the treatment of multiple sclerosis (MS). These neuropeptides, as well as those belonging to the tachykinin family exert pleiotropic effects, many of which are of relevance to central nervous system...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
